Does ipragliflozin prolong QTc interval in healthy male and female subjects : a phase I study?
No clinically meaningful QTc interval prolongation was observed in these healthy subjects who received ipragliflozin doses up to 600 mg/d for 7 days. ClinicalTrials.gov identifier: NCT01232413.
This meta-analysis suggests that heme iron intake was associated with an increased risk of CHD.